Results were presented on Monday for TRAILBLAZER-ALZ-2, a registration trial of the monoclonal antibody donanemab, which was previously announced as positive. The data were highly convincing that donanemab has a…
더 읽어보기
뉴스
MNT spoke with Dr. Karen D. Lincoln, a professor in the Department of Environmental and Occupational Health at the University of California, Irvine. She noted that while some evidence suggests…
더 읽어보기
The post Support Groups with Cleo Dougherty appeared first on UCI MIND.
더 읽어보기
The post 34th Annual Southern California Alzheimer’s Disease Research Conference appeared first on UCI MIND.
더 읽어보기
July 6, 2023—Today, the US Food and Drug Administration granted full approval to the drug lecanemab (brand name Leqembi®), a monoclonal antibody that has been demonstrated to lower levels of…
더 읽어보기
On June 9, The US Food and Drug Administration convened members of the updated Peripheral and Central Nervous System Drugs Advisory Committee to review the available data for lecanemab, the monoclonal…
더 읽어보기
UCI MIND Director, Dr. Joshua Grill, named one of this year’s OC50 (50 people shaping the future of healthcare in Orange County) in the Orange County Business Journal. Read the…
더 읽어보기
Masashi Kitazawa, Associate Professor of Environmental and Occupational Health, and his team found exposure to traffic-related air pollution led to memory loss and cognitive decline and triggered neurological pathways associated…
더 읽어보기
May 12, 2023–Brexpiprazole has now been approved by the FDA for the treatment of agitation in Alzheimer’s dementia. Agitated behaviors are common in those with moderate or advanced Alzheimer’s dementia…
더 읽어보기
May 3, 2023–Eli Lilly and company announced today (https://investor.lilly.com/news-releases/news-release-details/lillys-donanemab-significantly-slowed-cognitive-and-functional) the positive topline results from their Phase 3 clinical trial of donanemab, a monoclonal antibody that rapidly lowers beta amyloid levels…
더 읽어보기
New number crunching from the Alzheimer’s Orange County estimates that the number of folks enduring this sort of heartbreak has essentially doubled since 2014 in the O.C. That’s a startling…
더 읽어보기
On Monday, April 17th, 2023, the trainee led Research and Education in Memory Impairments and Neurological Disorders (REMIND) held its 14th annual Emerging Scientists Symposium. The event is designed to help early career…
더 읽어보기
Dr. Frank LaFerla, Dean of the School of Biological Sciences and UCI MIND faculty member speaks at local educational event for the Alzheimer’s Foundation of America. Read about the event…
더 읽어보기
UCI MIND faculty member and professor in the School of Public Health, Karen D. Lincoln, PhD, MSW, MA, FGSA, is featured in Authority Magazine as being one of the top inspirational…
더 읽어보기
OC World produced documentary “Hope Dies Last”, featuring UCI MIND faculty members, Drs. Joshua Grill and Leslie Thompson, wins the Golden Mike Award for best documentary. “Hope Dies Last” creates…
더 읽어보기
Message from the Director Dear Friends of UCI MIND, Advances in the field of Alzheimer’s disease (AD) research and the contributions of UCI MIND investigators remain tremendously exciting. Two new…
더 읽어보기
The UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND) is pleased to announce that the inaugural recipient of the “UCI MIND Joan and Don Beall Scholar Award”…
더 읽어보기